Wedbush initiated coverage on Bluebird Bio (NASDAQ: BLUE) with an Outperform rating and a price target of $32.25.

"We ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE